Ryungsa Kim - Concepedia

Author

Ryungsa Kim

Hiroshima University

Also Known As

JUNG YONG HONG, R KIM, R Kim, R. Kim, R. Y KIM, Ryeong Rea Kim, Ryungsa Kim

111

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Hiroshima University Hiroshima University Hospital Hiroshima International University Hiroshima City Asa Citizens Hospital Hiroshima Prefectural Hospital

About

Ryungsa Kim is an author at Hiroshima University specializing in medicine, oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	424
2	Cell Biology	11	11	344
3	Biochemistry	2	2	34
4	Health Sciences	1	1	15
5	Natural Sciences	1	1	16

Ryungsa Kim

Publications

Citations

H-Index

Page 1

	Year	Citations
Grapefruit juice ingestion significantly reduces talinolol bioavailability Ute I. Schwarz, D SEEMANN, Reinhard Oertel, Clinical Pharmacology & Therapeutics	2005	147
Caspase-dependent and -independent cell death pathways after DNA damage (Review) Ryungsa Kim, Manabu Emi, Kazuaki Tanabe Oncology Reports	2005	130
Targeted therapy against Bcl-2-related proteins in breast cancer cells Manabu Emi, Ryungsa Kim, Kazuaki Tanabe, Breast Cancer Research	2005	113
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice Ryungsa Kim, Naoki Hirabayashi, Masahiko Nishiyama, International Journal of Cancer Experimental StudiesNuclear EnzymesPathologyPharmacotherapyCancer Biology	1992	111
Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Ryungsa Kim, William T. Beck PubMed Hematological MalignancyChromatinGenome InstabilityC-jun ExpressionDna Topoisomerases	1994	44
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy Ryungsa Kim, Takanori Kin, William T. Beck Cancers	2024	42
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs Kazuaki Tanabe, Ryungsa Kim, Hideki Inoue, International Journal of Oncology Breast OncologyOncologyHer-2 Oligonucleotide TreatmentMedicineBreast Cancer Cells	2003	37
Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma Ryungsa Kim, Manabu Emi, Koji Arihiro, Cancer	2005	35
Preclinical evaluation of antisense <i>bcl</i>‐2 as a chemosensitizer for patients with gastric carcinoma Ryungsa Kim, Manabu Emi, Kazuaki Tanabe, Cancer	2004	34
A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Cancer Immunology Immunotherapy Preoperative ChemotherapyCancer ImmunosurveillanceBreast OncologyBreast Cancer PatientsMedicine	2019	28

Page 1